오가노이드 및 스페로이드 시장

The report examines the global organoids and spheroids market, covering key trends, challenges, and market developments. It provides market estimates through 2031 and analyzes the market by product type, application, end user, and region. The study also looks at the use of organoids and spheroids in drug discovery, personalized medicine, disease studies, toxicity testing, developmental biology, and regenerative medicine. It covers major end users, including pharmaceutical and biotechnology companies, research institutes, CROs, hospitals, and diagnostic centers, along with the competitive landscape, market shares, and rankings of key businesses.

Report Scope

This report provides an overview of the global organoids and spheroids market by analyzing its trends. The market is defined as the revenue generated by companies that derive their revenue from the sale of products and technologies used to develop organoids and spheroids, as well as companies that develop, grow, and commercialize organoid and spheroid models.

The report includes global revenue ($ millions), with 2025 as the base year, estimates for 2026, and forecasts through 2031. The market is segmented by product type, application, end user, and region. Based on product type, the market is categorized into organoid and spheroid. Based on applications, the market is segregated into drug discovery and personalized medicine, developmental biology, disease pathology studies, drug toxicity and efficacy testing, and regenerative medicine. The regions covered in this study are North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, with a focus on major countries in each region.

The report focuses on the significant trends and challenges that affect the market and vendor landscape. The market analysis covers the adoption of organoids and spheroids by various end users, including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, hospitals and diagnostic centers, and other end users.

The report concludes with an analysis of the competitive landscape, which provides rankings and market shares for key businesses in the global organoids and spheroids market.

Report Includes

• Overview of the global organoids and spheroids market, highlighting the growing use of advanced 3D cell culture models in biomedical research, drug development, and precision medicine
• Revenue analysis for the base year 2025, together with market estimates for 2026 and forecasts through 2031 across major regional markets
• Breakdown of the market by type, application, end user, and region
• Discussion of the major growth drivers, restraints, and emerging opportunities influencing the adoption of organoid and spheroid technologies worldwide
• Insights into technological advancements, including innovations in spheroid technologies, CRISPR integration, bioprinting, and patent activity supporting next-generation research models
• Regional assessment of North America, Europe, Asia-Pacific, South America, and the Middle East & Africa, with country-level analysis of leading markets
• Competitive landscape review featuring market share analysis, company rankings, and strategic initiatives undertaken by established companies and emerging innovators
• Profiles of leading market companies, highlighting their business overview, product offerings, and recent developments

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Market Definition
• Organoids and Spheroids Overview
• Organoids Versus Spheroids
• Future Directions in Organoids and Spheroids Market
• Porter's Five Forces Analysis
• Threat of New Entrants (Moderate)
• Bargaining Power of Suppliers (Moderate to High)
• Bargaining Power of Buyers (Moderate)
• Threat of Substitutes (Moderate)
• Level of Competitiveness (High)
• Macroeconomic Factors Analysis
• Demographic Trends and Disease Burden
• Government Funding and Research Investments
• Healthcare Expenditure and Economic Growth
• Regulatory and Ethical Evolution
• Impact of U.S.-Iran Conflict on the Organoids and Spheroids Market

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Adoption of 3D Cell Culture Models Over Conventional 2D Cell Cultures
• Shift Toward Human-Relevant Alternatives to Animal Testing in Preclinical Research
• Rising Adoption of Organoids and Spheroids in Oncology Drug Discovery
• Market Restraints
• High Costs of Advanced 3D Cell Culture Systems
• Lack of Standardized Protocols and Quality Control
• Reproducibility Challenges
• Market Opportunities
• Expansion of Personalized Medicine and Precision Oncology
• Growing Applications of Organoids in Regenerative Medicine and Tissue Engineering
• Emergence of Automated High-Throughput Organoid Platforms

Chapter 4 Regulatory Landscape

• Overview
• Regulations and Standards by Country or Region

Chapter 5 Emerging Technologies and Patent Analysis

• Overview
• Emerging Technologies
• Advances in 3D Spheroid Engineering Technologies
• Integration of CRISPR and Genome Editing with Organoid Models
• Emergence of 3D Bioprinting for Complex Organoid Assembly
• Patent Analysis
• By Year
• By Jurisdiction

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• Organoids
• Spheroids
• Market Analysis by Application
• Key Takeaways
• Drug Discovery and Personalized Medicine
• Developmental Biology
• Disease Pathology Studies
• Drug Toxicity and Efficacy Testing
• Regenerative Medicine
• Market Analysis by End User
• Key Takeaways
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Contract Research Organizations
• Hospitals and Diagnostic Centers
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Strategic Analysis

Chapter 8 Appendix

• Research Methodology
• References
• Abbreviations
• Company Profiles
• BIO-TECHNE
• CORNING INC.
• GREINER BIO-ONE INTERNATIONAL GMBH
• INSPHERO
• LONZA
• MERCK KGAA
• MOLECULAR DEVICES LLC.
• REVVITY
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.
• A Few Emerging Startups/Market Disruptors